Nagi S. El-Saghir

1.6k total citations
21 papers, 277 citations indexed

About

Nagi S. El-Saghir is a scholar working on Oncology, Cancer Research and Pathology and Forensic Medicine. According to data from OpenAlex, Nagi S. El-Saghir has authored 21 papers receiving a total of 277 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Oncology, 8 papers in Cancer Research and 3 papers in Pathology and Forensic Medicine. Recurrent topics in Nagi S. El-Saghir's work include Breast Cancer Treatment Studies (7 papers), Cancer Treatment and Pharmacology (4 papers) and Global Cancer Incidence and Screening (3 papers). Nagi S. El-Saghir is often cited by papers focused on Breast Cancer Treatment Studies (7 papers), Cancer Treatment and Pharmacology (4 papers) and Global Cancer Incidence and Screening (3 papers). Nagi S. El-Saghir collaborates with scholars based in Lebanon, United States and France. Nagi S. El-Saghir's co-authors include Ali Shamseddine, Alì Taher, Muhieddine Seoud, Ziad Salem, Ali Bazarbachi, Salah Termos, Marwan Ghosn, Ziad Salem, Abla Mehio Sibai and Ala I. Sharara and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and Annals of Surgical Oncology.

In The Last Decade

Nagi S. El-Saghir

21 papers receiving 273 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Nagi S. El-Saghir Lebanon 9 122 83 55 46 46 21 277
Saskia Luelmo Netherlands 11 233 1.9× 126 1.5× 39 0.7× 71 1.5× 69 1.5× 30 360
Malek M. Safa United States 9 125 1.0× 91 1.1× 102 1.9× 31 0.7× 37 0.8× 26 357
Irène Jiménez France 10 100 0.8× 39 0.5× 29 0.5× 31 0.7× 62 1.3× 34 304
Rabih Said United States 11 153 1.3× 118 1.4× 70 1.3× 27 0.6× 105 2.3× 33 390
Clara Lam United States 8 127 1.0× 30 0.4× 35 0.6× 50 1.1× 51 1.1× 20 339
Gary Zeger United States 12 156 1.3× 48 0.6× 45 0.8× 55 1.2× 151 3.3× 19 315
Johan Kurnianda Indonesia 10 176 1.4× 53 0.6× 35 0.6× 48 1.0× 86 1.9× 47 314
Sugganth Daniel United States 7 196 1.6× 70 0.8× 67 1.2× 46 1.0× 96 2.1× 26 313
Elena Tenti Italy 7 173 1.4× 103 1.2× 32 0.6× 62 1.3× 61 1.3× 37 390
Giovanni Tazzioli Italy 11 208 1.7× 128 1.5× 55 1.0× 107 2.3× 85 1.8× 43 489

Countries citing papers authored by Nagi S. El-Saghir

Since Specialization
Citations

This map shows the geographic impact of Nagi S. El-Saghir's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nagi S. El-Saghir with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nagi S. El-Saghir more than expected).

Fields of papers citing papers by Nagi S. El-Saghir

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nagi S. El-Saghir. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nagi S. El-Saghir. The network helps show where Nagi S. El-Saghir may publish in the future.

Co-authorship network of co-authors of Nagi S. El-Saghir

This figure shows the co-authorship network connecting the top 25 collaborators of Nagi S. El-Saghir. A scholar is included among the top collaborators of Nagi S. El-Saghir based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nagi S. El-Saghir. Nagi S. El-Saghir is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Adib, Salim M., et al.. (2020). Trends in Breast Cancer Staging at Diagnosis Associated with Screening Campaigns in Lebanon. Women s Health Reports. 1(1). 521–528. 5 indexed citations
2.
Azim, Hamdy A., Shaheenah Dawood, Nagi S. El-Saghir, Loay Kassem, & Hatem A. Azim. (2019). Understanding the benefits and challenges of first‐line cyclin‐dependent kinases 4 and 6 inhibitors in advanced breast cancer among postmenopausal women. The Breast Journal. 26(4). 630–642. 3 indexed citations
3.
Dittrich, Christian, Michael P. Kosty, S. Jezdic, et al.. (2016). Global Curriculum Edition 2016: European Society for Medical Oncology/American Society of Clinical Oncology Recommendations for Training in Medical Oncology. Journal of Clinical Oncology. 35(2). 254–255. 4 indexed citations
4.
Hortobágyi, Gabriel N., Nagi S. El-Saghir, Tanja Čufer, et al.. (2015). The American Society of Clinical Oncology's Efforts to Support Global Cancer Medicine. Journal of Clinical Oncology. 34(1). 76–82. 15 indexed citations
5.
Sbaity, Eman, et al.. (2014). Treatment of Contralateral Axillary Metastases: Palliative Vs Curative Dilemma. 4 indexed citations
6.
Zgheib, Nathalie K., Arafat Tfayli, Ali Bazarbachi, et al.. (2013). Genetic polymorphisms of CYP2E1, GST, and NAT2 enzymes are not associated with risk of breast cancer in a sample of Lebanese women. Mutation research. Fundamental and molecular mechanisms of mutagenesis. 747-748. 40–47. 23 indexed citations
7.
Haider, Syed, Arafat Tfayli, Ali Bazarbachi, et al.. (2013). Pharmacogenomics Variation in Drug Metabolizing Enzymes and Transporters in Relation to Docetaxel Toxicity in Lebanese Breast Cancer Patients: Paving the Way for OMICs in Low and Middle Income Countries. OMICS A Journal of Integrative Biology. 17(7). 353–367. 20 indexed citations
8.
El-Saghir, Nagi S., et al.. (2011). Isolated splenic metastasis from colorectal cancer. International Journal of Clinical Oncology. 16(4). 306–313. 33 indexed citations
9.
Hatoum, Hassan, Faek R. Jamali, Nagi S. El-Saghir, et al.. (2010). Ratio between positive lymph nodes and total excised axillary lymph nodes as an independent prognostic factor for overall survival in patients with nonmetastatic lymph node-positive breast cancer. Indian Journal of Surgical Oncology. 1(1). 68–75. 8 indexed citations
10.
Hatoum, Hassan, Faek R. Jamali, Nagi S. El-Saghir, et al.. (2010). Ratio Between Positive Lymph Nodes and Total Excised Axillary Lymph Nodes as an Independent Prognostic Factor for Overall Survival in Patients with Nonmetastatic Lymph Node-Positive Breast Cancer. Indian Journal of Surgical Oncology. 1(4). 305–312. 13 indexed citations
11.
Charafeddine, Khalil M., Hassan Hatoum, Zaher K. Otrock, et al.. (2009). Long-term outcome of adult acute lymphoblastic leukemia in Lebanon. Hematology/Oncology and Stem Cell Therapy. 2(2). 333–339. 7 indexed citations
12.
Hatoum, Hassan, Faek R. Jamali, Nagi S. El-Saghir, et al.. (2009). Ratio Between Positive Lymph Nodes and Total Excised Axillary Lymph Nodes as an Independent Prognostic Factor for Overall Survival in Patients with Nonmetastatic Lymph Node-Positive Breast Cancer. Annals of Surgical Oncology. 16(12). 3388–3395. 38 indexed citations
13.
El-Saghir, Nagi S., et al.. (2008). Modified resistance to chemotherapy and trastuzumab by bevacizumab in locally recurrent breast cancer. The Breast. 18(1). 66–68. 3 indexed citations
14.
El-Saghir, Nagi S., et al.. (2008). Hand-foot syndrome with docetaxel: a five-case series. Annals of Saudi Medicine. 28(5). 374–377. 5 indexed citations
15.
Shamseddine, Ali, Zaher K. Otrock, Maya Charafeddine, et al.. (2006). A Clinical Phase II Study of a Non-Anthracycline Sequential Combination of Cisplatin-Vinorelbine Followed by Docetaxel as First-Line Treatment in Metastatic Breast Cancer. Oncology. 70(5). 330–338. 2 indexed citations
16.
Shamseddine, Ali, et al.. (2006). Cisplatin and vinorelbine (PVn) for the treatment of advanced breast cancer: 10 years of experience.. PubMed. 52(3). 126–30. 1 indexed citations
17.
El-Saghir, Nagi S., Ihab I. El-Hajj, Jawad A. Makarem, & Zaher K. Otrock. (2006). Combined ovarian ablation and aromatase inhibition as first-line therapy for hormone receptor-positive metastatic breast cancer in premenopausal women: report of three cases. Anti-Cancer Drugs. 17(8). 999–1002. 4 indexed citations
18.
Shamseddine, Ali, Abla Mehio Sibai, Nagi S. El-Saghir, et al.. (2004). Cancer incidence in postwar Lebanon: findings from the first national population-based registry, 1998. Annals of Epidemiology. 14(9). 663–668. 51 indexed citations
19.
Shamseddine, Ali, Aref Chehal, Ihab M. Usta, et al.. (2004). Thrombotic thrombocytopenic purpura and pregnancy: report of four cases and literature review. Journal of Clinical Apheresis. 19(1). 5–10. 24 indexed citations
20.
Shamseddine, Ali, Elie Aoun, Nagi S. El-Saghir, et al.. (2004). Thrombotic thrombocytopenic purpura: 24 years of experience at the American University of Beirut Medical Center. Journal of Clinical Apheresis. 19(3). 119–124. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Saskia Luelmo Breakdown of academic impact, for papers by Malek M. Safa Breakdown of academic impact, for papers by Irène Jiménez Breakdown of academic impact, for papers by Rabih Said Breakdown of academic impact, for papers by Clara Lam Breakdown of academic impact, for papers by Gary Zeger Breakdown of academic impact, for papers by Johan Kurnianda Breakdown of academic impact, for papers by Sugganth Daniel Breakdown of academic impact, for papers by Elena Tenti Breakdown of academic impact, for papers by Giovanni Tazzioli
Rankless by CCL
2026